Veena Kalra

2.1k total citations
105 papers, 1.3k citations indexed

About

Veena Kalra is a scholar working on Molecular Biology, Psychiatry and Mental health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Veena Kalra has authored 105 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 21 papers in Psychiatry and Mental health and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Veena Kalra's work include Epilepsy research and treatment (15 papers), Metabolism and Genetic Disorders (12 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Veena Kalra is often cited by papers focused on Epilepsy research and treatment (15 papers), Metabolism and Genetic Disorders (12 papers) and Pharmacological Effects and Toxicity Studies (11 papers). Veena Kalra collaborates with scholars based in India, United States and Pakistan. Veena Kalra's co-authors include Sheffali Gulati, Madhulika Kabra, Madhumita Bhattacharyya, Tarun Dua, Jitendra Kumar Sahu, Ravindra Mohan Pandey, Naveen Sankhyan, Suvasini Sharma, Anuja Agarwala and Rachna Seth and has published in prestigious journals such as PLoS ONE, The Journal of Pediatrics and Epilepsia.

In The Last Decade

Veena Kalra

98 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veena Kalra India 20 416 314 241 186 180 105 1.3k
Baik‐Lin Eun South Korea 21 457 1.1× 500 1.6× 230 1.0× 83 0.4× 179 1.0× 84 1.4k
Sefer Kumandaş Türkiye 24 334 0.8× 371 1.2× 228 0.9× 127 0.7× 171 0.9× 100 1.5k
Hakan Gümüş Türkiye 24 299 0.7× 336 1.1× 200 0.8× 159 0.9× 119 0.7× 106 1.6k
Hüseyin Per Türkiye 24 328 0.8× 249 0.8× 197 0.8× 143 0.8× 138 0.8× 132 1.7k
Jitendra Kumar Sahu India 18 521 1.3× 375 1.2× 163 0.7× 109 0.6× 131 0.7× 152 1.3k
Luigi Titomanlio France 24 307 0.7× 410 1.3× 237 1.0× 85 0.5× 78 0.4× 92 1.6k
Cengiz Yakıncı Türkiye 17 165 0.4× 180 0.6× 152 0.6× 108 0.6× 61 0.3× 90 892
Avraham Zeharia Israel 25 358 0.9× 115 0.4× 721 3.0× 156 0.8× 63 0.3× 83 1.8k
Kun‐Long Hung Taiwan 16 133 0.3× 297 0.9× 137 0.6× 101 0.5× 91 0.5× 56 1.1k
Nadir E. Bharucha India 20 441 1.1× 286 0.9× 125 0.5× 140 0.8× 205 1.1× 41 1.9k

Countries citing papers authored by Veena Kalra

Since Specialization
Citations

This map shows the geographic impact of Veena Kalra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veena Kalra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veena Kalra more than expected).

Fields of papers citing papers by Veena Kalra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veena Kalra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veena Kalra. The network helps show where Veena Kalra may publish in the future.

Co-authorship network of co-authors of Veena Kalra

This figure shows the co-authorship network connecting the top 25 collaborators of Veena Kalra. A scholar is included among the top collaborators of Veena Kalra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veena Kalra. Veena Kalra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sankhyan, Naveen, Sheffali Gulati, Smriti Hari, et al.. (2013). Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: A cross sectional study. Epilepsy Research. 107(1-2). 121–126. 13 indexed citations
2.
Sahu, Jitendra Kumar, Sheffali Gulati, Savita Sapra, et al.. (2012). Effectiveness and Safety of Donepezil in Boys With Fragile X Syndrome. Journal of Child Neurology. 28(5). 570–575. 29 indexed citations
3.
Haldar, Sagarika, Naveen Sankhyan, Neera Sharma, et al.. (2012). Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA Impacts the Rapid Diagnosis of Tuberculous Meningitis in Children. PLoS ONE. 7(9). e44630–e44630. 42 indexed citations
4.
Arya, Ravindra, Sheffali Gulati, Madhulika Kabra, Jitendra Kumar Sahu, & Veena Kalra. (2011). Intranasal versus intravenous lorazepam for control of acute seizures in children: A randomized open‐label study. Epilepsia. 52(4). 788–793. 64 indexed citations
5.
Gulati, Sheffali, Madhulika Kabra, Anuja Agarwala, et al.. (2011). Efficacy of 4:1 (classic) versus 2.5:1 ketogenic ratio diets in refractory epilepsy in young children: A randomized open labeled study. Epilepsy Research. 96(1-2). 96–100. 61 indexed citations
6.
Gupta, Neerja, Manju Ghosh, Manoj Kumar, et al.. (2010). Molecular and structural analysis of metachromatic leukodystrophy patients in Indian population. Journal of the Neurological Sciences. 301(1-2). 38–45. 17 indexed citations
7.
Kalra, Veena, Rachna Seth, Devendra Mishra, & Narayan Chandra Saha. (2010). Clobazam in refractory childhood epilepsy. The Indian Journal of Pediatrics. 77(3). 263–266. 15 indexed citations
8.
Sapra, Savita, Manju Ghosh, Neerja Gupta, et al.. (2009). Rapid Detection of Deletions in Hotspot C-Terminal Segment Region of MECP2 by Routine PCR Method: Report of Two Classical Rett Syndrome Patients of Indian Origin. Genetic Testing and Molecular Biomarkers. 13(2). 277–280. 4 indexed citations
9.
Kalra, Veena, et al.. (2009). Novel human pathological mutations. Gene symbol: ABCD1. Disease: Adrenoleukodystrophy.. PubMed. 126(2). 335–6. 2 indexed citations
10.
Sharma, Suvasini, Sheffali Gulati, Veena Kalra, Anuja Agarwala, & Madhulika Kabra. (2009). Seizure control and biochemical profile on the ketogenic diet in young children with refractory epilepsy—Indian experience. Seizure. 18(6). 446–449. 49 indexed citations
11.
Kumar, Neeraj, et al.. (2008). De Novo ABCD1 Gene Mutation in an Indian Patient With Adrenoleukodystrophy. Pediatric Neurology. 39(4). 289–292. 5 indexed citations
12.
Kabra, Madhulika, et al.. (2006). Fragile X screening for FRAXA and FRAXE mutations using PCR based studies: Results of a five year study. Indian journal of human genetics. 12(1). 17–17. 9 indexed citations
13.
Gulati, Sheffali, et al.. (2005). Duchenne Muscular Dystrophy: Prevalence and patterns of cardiac involvement. The Indian Journal of Pediatrics. 72(5). 389–393. 26 indexed citations
14.
Gulati, Sheffali, et al.. (2004). Erythema annulare centrifugum with autoimmune hepatitis. The Indian Journal of Pediatrics. 71(6). 541–542. 11 indexed citations
15.
Gulati, Sheffali & Veena Kalra. (2003). Stroke in children. The Indian Journal of Pediatrics. 70(8). 639–648. 15 indexed citations
16.
Kalra, Veena, et al.. (2003). Blood Lead Levels and Risk Factors for Lead Toxicity in Children from Schools and an Urban Slum in Delhi. Journal of Tropical Pediatrics. 49(2). 121–123. 27 indexed citations
17.
Kalra, Veena. (2003). Management of childhood epilepsy. The Indian Journal of Pediatrics. 70(2). 147–151. 3 indexed citations
18.
Gulati, Sheffali, et al.. (2001). Mitochondrial myopathy presenting as ataxia with dilated cardiomyopathy. The Indian Journal of Pediatrics. 68(4). 347–350. 1 indexed citations
19.
Kalra, Veena, et al.. (2000). Plumbism—A mimicker of common childhood symptoms. The Indian Journal of Pediatrics. 67(2). 81–86. 7 indexed citations
20.
Kalra, Veena. (1996). Report from india, No. 2 Child neurology in India — A voyage begun. Brain and Development. 18(1). 84–85. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baik‐Lin Eun Breakdown of academic impact, for papers by Sefer Kumandaş Breakdown of academic impact, for papers by Hakan Gümüş Breakdown of academic impact, for papers by Hüseyin Per Breakdown of academic impact, for papers by Jitendra Kumar Sahu Breakdown of academic impact, for papers by Luigi Titomanlio Breakdown of academic impact, for papers by Cengiz Yakıncı Breakdown of academic impact, for papers by Avraham Zeharia Breakdown of academic impact, for papers by Kun‐Long Hung Breakdown of academic impact, for papers by Nadir E. Bharucha
Rankless by CCL
2026